Literature DB >> 28194252

A simultaneous minimally invasive approach to treat a patient with coronary artery disease and metastatic lung cancer.

Yuanhao Fu1, Lufeng Zhang1, Ling Ji2, Chenyang Xu2.   

Abstract

Concurrent lung cancer and coronary artery disease requiring treatment with percutaneous coronary intervention or coronary artery bypass grafting is not rare. An individualized perioperative anticoagulation regimen and minimal surgical trauma will benefit the patient's postoperative recovery. We successfully treated a 68-year-old female patient with a lesion in the left anterior descending artery and metastatic right lung carcinoma by simultaneous minimally invasive direct coronary artery bypass grafting via a small left thoracotomy and thoracoscopic wedge resection of the lung lesion. She recovered and was discharged on the eighth postoperative day. The patient showed no symptoms of myocardial ischemia postoperatively. Computed tomography scan did not indicate metastatic lesion of lung carcinoma at 1-year follow-up. In conclusion, minimally invasive direct coronary artery bypass grafting combined with thoracoscopic wedge resection is an effective minimally invasive treatment for concurrent lung cancer and coronary artery disease. This technique eliminates the risk of perioperative bleeding and provides satisfactory mid-term follow-up results.

Entities:  

Keywords:  coronary artery bypass graft surgery; minimally invasive surgery; simultaneous management; video-assisted thoracoscopic surgery

Year:  2016        PMID: 28194252      PMCID: PMC5299078          DOI: 10.5114/wiitm.2016.63987

Source DB:  PubMed          Journal:  Wideochir Inne Tech Maloinwazyjne        ISSN: 1895-4588            Impact factor:   1.195


Introduction

Concurrent lung cancer and coronary artery disease requiring treatment with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is not rare in clinical practice [1]. An individualized perioperative anticoagulation regimen and minimal surgical trauma will benefit the patient’s postoperative recovery. Dual antiplatelet therapy after PCI may induce intraoperative and postoperative bleeding. Conventional CABG via sternotomy may add operative trauma in elderly and weak patients. We herein report a minimally invasive approach involving a combination of minimally invasive direct coronary artery bypass (MIDCAB) and thoracoscopic wedge resection of a right lung lesion for simultaneous treatment of coronary artery disease and lung cancer.

Case report

A 68-year-old woman with a history of colon cancer was referred for thoracoscopic resection of a metastatic lesion in the right inferior pulmonary lobe (Photo 1). Preoperative coronary angiography revealed total occlusion of the left anterior descending artery (LAD) after the origin of the first diagonal branch (Photo 2). Percutaneous coronary intervention was not performed because of its technical difficulty and contraindication for perioperative anticoagulation. To minimize the operative trauma, we performed simultaneous MIDCAB via a small left thoracotomy and thoracoscopic wedge resection of the lung lesion.
Photo 1

Chest computed tomography revealed a metastatic lesion in the right inferior pulmonary lobe

Photo 2

Coronary angiography revealed total occlusion of the left anterior descending artery after the origin of the first diagonal branch

Chest computed tomography revealed a metastatic lesion in the right inferior pulmonary lobe Coronary angiography revealed total occlusion of the left anterior descending artery after the origin of the first diagonal branch The patient was anesthetized and intubated with a double-lumen endotracheal tube. Single-lung ventilation was used to facilitate exposure for harvesting of the left internal thoracic artery. The patient was positioned supine with 30° rotation toward the right decubitus position by means of a rolled towel. External pads for emergency defibrillation were placed on the right anterior and left posterior sides of the chest wall. A 5-cm left anterior thoracotomy incision was then created along the inframammary line and tunneled into the fourth intercostal space according to the preoperative chest X-ray and coronary angiography images. After harvesting of the left internal thoracic artery, a pericardial incision was made to expose and stabilize the LAD with a specially designed minimally invasive stabilizer. The coronary anastomosis was performed using a continuous running suture technique (8-0 suture) and intracoronary shunting. After heparin neutralization and switching of the single-lung ventilation to the other side, the patient was positioned supine with 30° rotation toward the left decubitus position. A 4-cm incision in the fifth intercostal space was made along the right anterior axillary line for wedge resection of the dorsal segment of the right inferior pulmonary lobe using a thoracoscopic linear stapler with a blue reload. After the surgery, the patient was transferred to the intensive care unit and recovered well. She was discharged on postoperative day 8. A perioperative red blood cell transfusion was not necessary. The patient’s postoperative mechanical ventilation time was 12 h. Postoperative transthoracic echocardiography showed a normal ejection fraction and heart chamber. Pathologic examination of the lung lesion showed a moderately differentiated metastatic colonic adenocarcinoma. The lesion was positive for cytokeratin (CK), CK20, Ki-67, CDX2, and carcinoembryonic antigen as determined by immunohistochemistry. The patient was clinically well at the 1-year follow-up visit. She was in NYHA I without symptoms of myocardial ischemia. Chest computed tomography showed no indication of a lung mass at the 1-year follow-up.

Discussion

Concomitant coronary artery disease and lung cancer is not uncommon and may pose a serious surgical dilemma [1, 2]. No formal consensus regarding the optimal treatment of patients with cancer and coronary artery disease, whether by contemporary or staged surgical treatment, has been reached [3, 4]. Cancer resection followed by CABG may increase the perioperative and intraoperative cardiogenic risk to the patient, while CABG followed by cancer resection is associated with a risk of intraoperative carcinoma metastasis. Combined one-stage cancer resection and CABG may be associated with a high risk of surgical trauma to the patient. A one-stage, minimally invasive combined surgical procedure provides a new option for these patients. The advantages of a one-stage approach include use of fewer anesthetic agents, less operative stress and pain, a shorter hospital stay, lower therapeutic cost, and less delay of tumor treatment [2-5]. Minimally invasive direct coronary artery bypass for revascularization of the LAD has become a routine operation in clinical practice. Minimally invasive direct coronary artery bypass is associated with substantially lower risks of cancer metastasis, intraoperative hemorrhage, sudden inflammatory response syndrome, and pulmonary edema than is cardiopulmonary bypass [6-8]. Furthermore, MIDCAB without sternotomy can provide similar long-term graft patency and satisfactory outcomes [6, 8]. In the present case, the combination of MIDCAB and thoracoscopic wedge resection of the metastatic lung lesion had excellent short- and mid-term results.

Conclusions

Minimally invasive direct coronary artery bypass combined with thoracoscopic wedge resection of the pulmonary lobe is an effective minimally invasive treatment for concurrent lung cancer and coronary artery disease. This technique eliminates the risk of perioperative bleeding and provides satisfactory mid-term follow-up results.
  8 in total

1.  Results of combined pulmonary resection and cardiac operation.

Authors:  V Rao; T R Todd; R D Weisel; M Komeda; G Cohen; J S Ikonomidis; G T Christakis
Journal:  Ann Thorac Surg       Date:  1996-08       Impact factor: 4.330

2.  Seven-year follow-up after minimally invasive direct coronary artery bypass: experience with more than 1300 patients.

Authors:  David M Holzhey; Stephan Jacobs; Michael Mochalski; Thomas Walther; Holger Thiele; Friedrich W Mohr; Volkmar Falk
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

Review 3.  A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery.

Authors:  Zehra Jaffery; Marcin Kowalski; W Douglas Weaver; Sanjaya Khanal
Journal:  Eur J Cardiothorac Surg       Date:  2007-02-14       Impact factor: 4.191

4.  Lung cancer resection or aortic graft replacement with simultaneous myocardial revascularization without cardiopulmonary bypass.

Authors:  A Elami; A Korach; E Rudis
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

Review 5.  Combined off-pump coronary artery bypass surgery and pulmonary resection.

Authors:  Pankaj Saxena; Robert K W Tam
Journal:  Ann Thorac Surg       Date:  2004-08       Impact factor: 4.330

6.  The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease.

Authors:  Wojciech Dyszkiewicz; Marek Jemielity; Cezary Piwkowski; Mariusz Kasprzyk; Bartłomiej Perek; Lukasz Gasiorowski; Elzbieta Kaczmarek
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-25       Impact factor: 4.191

7.  Simultaneous lung resection for cancer and myocardial revascularization without cardiopulmonary bypass (off-pump coronary artery bypass grafting).

Authors:  Wojciech Dyszkiewicz; Marek M Jemielity; Cezary T Piwkowski; Bartłomiej Perek; Mariusz Kasprzyk
Journal:  Ann Thorac Surg       Date:  2004-03       Impact factor: 4.330

8.  Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization - analysis of 300 cases.

Authors:  Lufeng Zhang; Zhongqi Cui; Zhiming Song; Hang Yang; Yuanhao Fu; Yichen Gong; Yunpeng Ling
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-11-30       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.